Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Rapha Capital Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 4
Rounds per year 1.33
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 2
Key employees 1

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Health Diagnostics
  • Pharmaceutical
Summary

The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund.

Among the most popular portfolio startups of the fund, we may highlight AsclepiX Therapeutics, Poseida Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Genetics.

Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Rapha Capital Management, startups are often financed by Malin Corporation, Vivo Capital, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, TEDCO, Salem Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Rapha Capital Management:
Typical Co-investors
Rapha Capital Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Rapha Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Boyu Cangqiong Keji Youxian Gongsi Beijing, Beijing, China
Creation Venture Partners Chaoyang, China, Liaoning
D-Ax Corporate Venture Capital Stockholm, Stockholm County, Sweden
Dangdai Zhiye China, Hong Kong, Hong Kong Island
DFW Capital New Jersey, Teaneck, United States
Digital Irish Angels New York, New York, United States
Duquesne Family Office -
Euromate BV Breda, Netherlands, North Brabant
Hongxin Ziben China, Fujian, Xiamen
Legal & General Capital England, London, United Kingdom
Planet N Group of Companies England, London, United Kingdom
PTC Therapeutics New Jersey, South Plainfield, United States
Seentao Technology Beijing, Beijing, China
Stellar Internet GmbH Germany, Hürth, Nordrhein-Westfalen
The Blockchainer China, Shanghai
The Chainsmokers New York, New York, United States
Toyota Systems Aichi Prefecture, Japan, Nagoya
Venture Strategy Partners California, San Francisco, United States
Venturion Capital Dedham, Massachusetts, United States
Wire Accelerator -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$10M26 Jul 2023 Baltimore, Maryland, United States

Fize Medical

Health Care
Medical Device
$5M06 Apr 2021 Israel, Center District, Israel

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$35M24 Jun 2020 Baltimore, Maryland, United States

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$142M22 Apr 2019 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Rapha Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 26M
Rounds per year 1.33
Peak activity year 2021
Lead investments 0
Follow on index 0.50
Exits 2
Group Appearance index 0.62

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$10M26 Jul 2023 Baltimore, Maryland, United States

Fize Medical

Health Care
Medical Device
$5M06 Apr 2021 Israel, Center District, Israel

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$35M24 Jun 2020 Baltimore, Maryland, United States

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$142M22 Apr 2019 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: